Perpetual Ltd’s Corcept Therapeutics CORT Stock Holding History

Perpetual Ltd’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$206K	Buy	+1,789	New	+$192K	﹤0.01%	389

Other funds holding CORT

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Brown Capital Management Baltimore, Maryland $527M AUM 33.67% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Stanley-Laman Group Berwyn, Pennsylvania $915M AUM 50.26% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return

Perpetual Ltd's CORT Position: Q3 2026 in Review

Perpetual Ltd opened a new position in Corcept Therapeutics (CORT) in Q3 2026: 1,789 shares worth $206K. The stake represents ﹤0.01% of the portfolio and ranks #389 among its holdings.

118 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

Perpetual Ltd held 1,789 shares of Corcept Therapeutics worth $206K as of Q3 2026.
Corcept Therapeutics was a new Perpetual Ltd position in Q3 2026.
Corcept Therapeutics made up ﹤0.01% of Perpetual Ltd's portfolio in Q3 2026, its #389 holding.
118 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Perpetual Ltd's 13F filing for Q3 2026, filed 13 Oct 2026.